AstraZeneca delivers strong start to year after Q1 sales and earnings beat expectations
-Better than expected Q1 sales and profit-2023 guidance reiterated-Strong pipeline momentumPharmaceutical giant AstraZeneca (AZN) delivered better than expected first quarter sales and earnings on Thursday and reaffirmed full year...
27 April 2023